Urofollitropin

Urofollitropin is a medication used in assisted reproductive technology (ART) to stimulate ovarian follicle development in women undergoing fertility treatments. It belongs to the class of gonadotropins and mimics the action of follicle-stimulating hormone (FSH) in the body.

Indications

Treatment of infertility in women due to inadequate FSH production Stimulation of ovarian follicles in preparation for assisted reproductive procedures such as in vitro fertilization (IVF) Used in combination with other medications for controlled ovarian hyperstimulation

Dosage

The dosage of Urofollitropin is individualized based on the patient's ovarian response and treatment protocol established by the fertility specialist. It is typically administered via subcutaneous injection once daily.

Contra-Indications

-Hypersensitivity to Urofollitropin or any of its components -Ovarian cysts or enlargement not due to polycystic ovarian syndrome (PCOS) -Pregnancy or breastfeeding

Special Precautions

-Use under the supervision of a qualified fertility specialist -Monitoring of ovarian response through ultrasound and hormone level assessments is essential -Follow dosing instructions carefully to minimize the risk of ovarian hyperstimulation syndrome (OHSS)

Side Effects

-Common side effects include injection site reactions, abdominal discomfort, and nausea -Rare but serious side effects may include ovarian hyperstimulation syndrome (OHSS), ovarian torsion, and allergic reactions

Drug Interactions

-No significant drug interactions have been reported with Urofollitropin -However, inform the healthcare provider about all medications, including over-the-counter and herbal supplements